Accessibility Menu
 
Entourage Health logo

Entourage Health

(OTC) ETRGF

Current PriceN/A
Market CapN/A
Since IPO (2017)-99%
5 Year-99%
1 Year-49%
1 Month+18%

Entourage Health Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$41.46M

Net Income (TTM)

$42.16M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

ETRGF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Entourage Health

Industry

Pharmaceuticals

CEO

George Scorsis, MBA

Headquarters

Toronto, ON M5V 2A1, CA

ETRGF Financials

Key Financial Metrics (TTM)

Gross Margin

9%

Operating Margin

-53%

Net Income Margin

-1%

Return on Equity

37%

Return on Capital

15%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$3.71M

Operating Income

$21.38M

EBITDA

$21.40M

Operating Cash Flow

$10.24M

Capital Expenditure

$1.20M

Free Cash Flow

$11.44M

Cash & ST Invst.

$11.15M

Total Debt

$161.58M

Entourage Health Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$9.55M

+9.1%

Gross Profit

$2.87M

+17.7%

Gross Margin

30.08%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$8.37M

+15.5%

EBITDA

$1.12M

+67.1%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$178.29M

-22.2%

Accounts Receivable

$3.82M

-5.2%

Inventory

$10.95M

-30.4%

Long Term Debt

$6.80M

+9.1%

Short Term Debt

$175.00M

+17.5%

Return on Assets

-1.47%

N/A

Return on Invested Capital

15.17%

N/A

Free Cash Flow

$1.00M

+1667.9%

Operating Cash Flow

$1.05M

+23.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PRXTFPure Extracts Technologies Corp.
$0.01-12.90%
NVIVQInVivo Therapeutics Holdings Corporation
$0.37+12.12%
SLGWFSLANG Worldwide Inc.
$0.00+47.62%
RGTPQRegenETP, Inc.
$0.16+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
EFOIEnergy Focus
$7.72+2.69%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.69+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$58.40+0.03%
CRMLCritical Metals
$13.14+0.42%

Questions About ETRGF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.